Breaking News Bar

Business News and Information

Endocyte Reaches Analyst Target Price

In recent trading, shares of Endocyte Inc (ECYT) have crossed above the average analyst 12-month target price of $23.33, changing hands for $23.39/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear